USPTO serial 79235946
SLAMSEQ
Reviewed by CopyMark Law Group
Reg. 5658617Status 707Registered
- Filing date
- Status date
- Registration date
- Jan 22, 2019
- Examiner
- GLASSER, CARYN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with SLAMSEQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
IMBA - Institut für Molekulare Biotechnologie GmbH
Wien, AT
Other trademarks owned by IMBA - Institut für Molekulare Biotechnologie GmbH
IMBA - Institut für Molekulare Biotechnologie GmbH
Wien, AT
Other trademarks owned by IMBA - Institut für Molekulare Biotechnologie GmbH
IMBA - Institut für Molekulare Biotechnologie GmbH
Wien, AT
Other trademarks owned by IMBA - Institut für Molekulare Biotechnologie GmbH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard Fox Rothschild LLP212 Carnegie Center, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biochemical preparations for industrial and scientific purposes; chemical preparations for biotechnical purposes (industrial); chemical preparations for use in the development of biotechnological products for industrial and scientific purposes; chemical reagents and preparations for scientific purposes; chemical substances for analysis in laboratories and for use in kits; diagnostic reagents for in-vitro use in clinical chemistry; diagnostic preparations, except for medical or veterinary purposes; enzymes, in particular for use in kits and for use in effecting DNA-analysis or RNA-analysis and for enzyme preparations; all aforementioned goods for industrial and scientific purposes; reagents for scientific purposes | ACTIVE | — |
| 005 | [ Pharmaceutical products, namely, nucleic acid molecules for use in identification of genotypes, for the preparation of biopolymer profiles, for the detection of diseases, for the detection of the progression of diseases as well as for the detection of reactions to medicines; diagnostic reagents for medical purposes in the diagnosis of inflammations, infections, diseases of the central nervous system, cardiovascular, neurologic, endocrine, autoimmune and genetic diseases and of cancer, consisting of reagents, processing chemicals and nucleic acid molecules; medical diagnostic test kits for the detection of pathogens in the environment; clinical and diagnostic reagents and preparations for medical and veterinary purposes; medical diagnostic test kits for identification, quantification and analysis of DNA or RNA; reagents and enzymes for use with effecting DNA- or RNA-analysis for medical purposes ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research, development, diagnosis and analysis in the field of diagnostic chemicals and reagents, sorting of nucleotides, separation processes and cleaning processes, chemical screening analysis and effecting of diagnostic, forensic and genetic-medical tests for thirds; scientific research and development for thirds in the fields of diagnostic chemical agents and reagents for use as diagnostic, therapeutic preparations, as well as chemical screenings and diagnosis for thirds; scientific research and development of pharmaceutical preparations for sanitary use; design of new products regarding pharmaceutical products; quality tests and quality control of scientific analyses relating to nucleic acids; scientific analyses relating to nucleic acids, in particular for detection purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IMBA - Institut für Molekulare Biotechnologie GmbH
- Other trademarks owned by IMBA - Institut für Molekulare Biotechnologie GmbH
- Other trademarks owned by IMBA - Institut für Molekulare Biotechnologie GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SLAMSEQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 31, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 31, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 21, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 21, 2025 | NA15 | SEC. 15 ACKNOWLEDGEMENT - E-MAILED | — |
| May 21, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 21, 2025 | 15AK | REGISTERED - SEC. 15 ACKNOWLEDGED | — |
| May 21, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| May 19, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 11, 2025 | E15R | TEAS SECTION 15 RECEIVED | — |
| Jan 22, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 22, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 26, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 1, 2019 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 8, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 8, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 22, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 22, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 6, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 6, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 17, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 17, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 17, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 27, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 18, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 18, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 11, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 7, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 5, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |